Email received yesterday from Oil & Energy Investor -
Dear Reader,
Yesterday, we revealed a project that's been in development for more than six months.
Our Director of Venture Capital and Technology Investing, Michael Robinson, has been working directly with the CEO of a small biotech firm in California.
This firm has a monopoly over a breakthrough called living metal.
Based on the 124 advanced clinical trials currently underway, it's now believed that this discovery could be at the center of a series of miraculous treatments for Alzheimer's, cancer, arthritis, and much more.
Which is why, almost every major pharmaceutical company is currently paying $141,748 for a thimble full of it.
In our exclusive presentation, the CEO of this biotech firm will explain everything you need to know about this living metal. He will even give you a tour of the facility it's harvested in.
Now, this is why you will want to pay close attention to what he has to say.
The CEO has told us that his company is set to go public on the NASDAQ as soon as August 31st.
Michael Robinson will show you a way to claim a large stake in it BEFORE that NASDAQ listing happens.
And, before sales of this firm's living metal spike from $2.63 million to $620 million over the next 15 months. If that projection proves correct, it'll represent a 23,474% surge in revenue.
However, due to the small size of this company, we can only share this with so many people. So, I don't know how long we'll be able to keep this presentation online.
Click here for a private airing of this presentation...
To Your Success,
Mike Ward
Publisher, Oil & Energy Investor
News 
Market Data 
Discover 
